Inspire Medical Systems Inc
Inspire Medical Systems's GHG Emissions Data Preview
In 2023, Inspire Medical Systems completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
Inspire Medical Systems has also provided a category-level breakdown for 10 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2023 | 2022 | 2021 | 2020 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
a
a
a
a
a
a
a
a
a
aVerified Sources Behind Inspire Medical Systems’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Inspire Medical Systems’s data sources below and access millions more through our Disclosure Search.
Insights into Inspire Medical Systems's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of Inspire Medical Systems amounted to 452.37 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Inspire Medical Systems's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Inspire Medical Systems's Scope 1 emissions?
In 2023, the total Scope 1 emissions of Inspire Medical Systems were 50.63 metric tons of CO₂ equivalent (tCO₂e). a
What are Inspire Medical Systems's Scope 2 emissions?
In 2023, Inspire Medical Systems reported Scope 2 greenhouse gas (GHG) emissions of 401.74 tCO₂e without specifying the calculation method. a
What methodology does Inspire Medical Systems use for Scope 2 reporting?
In 2023, Inspire Medical Systems reported its Scope 2 emissions using an unspecified methodology. a
Inspire Medical Systems's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into Inspire Medical Systems's Value Chain Emissions
In 2023, Inspire Medical Systems reported 55,766.65 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a
The 2023 disclosure of Inspire Medical Systems includes a breakdown across 10 of the 15 Scope 3 categories defined by the GHG Protocol, up from 0 in , reflecting improved emissions accounting practices and greater transparency across the company's value chain a
Inspire Medical Systems's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are Inspire Medical Systems's Scope 3 emissions?
In 2023, Inspire Medical Systems reported total Scope 3 emissions of 55,766.65 metric tons of CO₂ equivalent (tCO₂e). a
Approximately 98.1% of these emissions originated from upstream activities such as purchased goods and capital goods, while 1.9% came from downstream activities like product use, distribution, and end-of-life treatment. a
What categories of Scope 3 emissions does Inspire Medical Systems disclose?
In 2023, Inspire Medical Systems reported emissions for 10 out of the 15 Scope 3 categories defined by the GHG Protocol. a
This reflects a high level of granularity and transparency in the company's emissions reporting.
What are the main sources of Inspire Medical Systems's Scope 3 emissions?
In 2023, the largest contributors to Inspire Medical Systems's Scope 3 emissions were: a
- Purchased Goods and Services (Cat. 1): 41,471.85 tCO₂e (74.37%)
- Business Travel (Cat. 6): 6,602.15 tCO₂e (11.84%)
- Capital Goods (Cat. 2): 3,981.71 tCO₂e (7.14%)
Inspire Medical Systems's Scope 3 Emissions by Categories
Insights into Inspire Medical Systems’s GHG Emissions Intensity Compared to Industry Peers
In 2023, Inspire Medical Systems reported Scope 1 greenhouse gas (GHG) emissions of 50.63 tCO₂e and total revenues of USD 625 millions. This translates into an emissions intensity of 0.08 tCO₂e per millions USD. a
Inspire Medical Systems's Scope 1 Emissions Intensity Compared to Peers
How does Inspire Medical Systems's GHG emissions intensity compare to its peers?
In 2023, Inspire Medical Systems reported a Scope 1 emissions intensity of 0.08 tCO₂e per millions USD. Compared to the peer group median of 2.56 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a
Where does Inspire Medical Systems rank on GHG emissions intensity within its industry?
In 2023, Inspire Medical Systems ranked 1 out of 20 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
This places Inspire Medical Systems among the top performers, with one of the lowest emissions intensities relative to peers. a
Insights into Inspire Medical Systems's Total Carbon Footprint
In 2023, Inspire Medical Systems reported a total carbon footprint of 56,219.02 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. a
The largest contributor to Inspire Medical Systems's total carbon footprint was Scope 3 emissions, accounting for 99.2% of the company's total carbon footprint, followed by Scope 2 emissions at 0.71%. a